{"type":"journal_article","department":[{"_id":"35"},{"_id":"22"}],"language":[{"iso":"eng"}],"publisher":"American Association for Cancer Research (AACR)","user_id":"49428","author":[{"first_name":"Jana","full_name":"Samarin, Jana","last_name":"Samarin"},{"last_name":"Rehm","full_name":"Rehm, Margot","first_name":"Margot"},{"first_name":"Bettina","orcid":"0000-0001-5351-1785","id":"49428","last_name":"Krueger","full_name":"Krueger, Bettina"},{"first_name":"Jens","last_name":"Waschke","full_name":"Waschke, Jens"},{"first_name":"Margarete","last_name":"Goppelt-Struebe","full_name":"Goppelt-Struebe, Margarete"}],"issue":"2","volume":7,"title":"Up-Regulation of Connective Tissue Growth Factor in Endothelial Cells by the Microtubule-Destabilizing Agent Combretastatin A-4","year":"2009","date_created":"2024-06-30T13:47:10Z","date_updated":"2024-06-30T13:47:22Z","doi":"10.1158/1541-7786.mcr-08-0292","status":"public","_id":"54932","citation":{"bibtex":"@article{Samarin_Rehm_Krueger_Waschke_Goppelt-Struebe_2009, title={Up-Regulation of Connective Tissue Growth Factor in Endothelial Cells by the Microtubule-Destabilizing Agent Combretastatin A-4}, volume={7}, DOI={10.1158/1541-7786.mcr-08-0292}, number={2}, journal={Molecular Cancer Research}, publisher={American Association for Cancer Research (AACR)}, author={Samarin, Jana and Rehm, Margot and Krueger, Bettina and Waschke, Jens and Goppelt-Struebe, Margarete}, year={2009}, pages={180–188} }","mla":"Samarin, Jana, et al. “Up-Regulation of Connective Tissue Growth Factor in Endothelial Cells by the Microtubule-Destabilizing Agent Combretastatin A-4.” Molecular Cancer Research, vol. 7, no. 2, American Association for Cancer Research (AACR), 2009, pp. 180–188, doi:10.1158/1541-7786.mcr-08-0292.","chicago":"Samarin, Jana, Margot Rehm, Bettina Krueger, Jens Waschke, and Margarete Goppelt-Struebe. “Up-Regulation of Connective Tissue Growth Factor in Endothelial Cells by the Microtubule-Destabilizing Agent Combretastatin A-4.” Molecular Cancer Research 7, no. 2 (2009): 180–188. https://doi.org/10.1158/1541-7786.mcr-08-0292.","ieee":"J. Samarin, M. Rehm, B. Krueger, J. Waschke, and M. Goppelt-Struebe, “Up-Regulation of Connective Tissue Growth Factor in Endothelial Cells by the Microtubule-Destabilizing Agent Combretastatin A-4,” Molecular Cancer Research, vol. 7, no. 2, pp. 180–188, 2009, doi: 10.1158/1541-7786.mcr-08-0292.","apa":"Samarin, J., Rehm, M., Krueger, B., Waschke, J., & Goppelt-Struebe, M. (2009). Up-Regulation of Connective Tissue Growth Factor in Endothelial Cells by the Microtubule-Destabilizing Agent Combretastatin A-4. Molecular Cancer Research, 7(2), 180–188. https://doi.org/10.1158/1541-7786.mcr-08-0292","ama":"Samarin J, Rehm M, Krueger B, Waschke J, Goppelt-Struebe M. Up-Regulation of Connective Tissue Growth Factor in Endothelial Cells by the Microtubule-Destabilizing Agent Combretastatin A-4. Molecular Cancer Research. 2009;7(2):180–188. doi:10.1158/1541-7786.mcr-08-0292","short":"J. Samarin, M. Rehm, B. Krueger, J. Waschke, M. Goppelt-Struebe, Molecular Cancer Research 7 (2009) 180–188."},"publication":"Molecular Cancer Research","page":"180–188","abstract":[{"lang":"eng","text":"Incubation of microvascular endothelial cells with combretastatin A-4 phosphate (CA-4P), a microtubule-destabilizing compound that preferentially targets tumor vessels, altered cell morphology and induced scattering of Golgi stacks. Concomitantly, CA-4P up-regulated connective tissue growth factor (CTGF/CCN2), a pleiotropic factor with antiangiogenic properties. In contrast to the effects of other microtubule-targeting agents such as colchicine or nocodazole, up-regulation of CTGF was only detectable in sparse cells, which were not embedded in a cell monolayer. Furthermore, CA-4P induced CTGF expression in endothelial cells, forming tube-like structures on basement membrane gels. Up-regulation of CTGF by CA-4P was dependent on Rho kinase signaling and was increased when p42/44 mitogen-activated protein kinase was inhibited. Additionally, FoxO transcription factors were identified as potent regulators of CTGF expression in endothelial cells. Activation of FoxO transcription factors by inhibition of phosphatidylinositol 3-kinase/AKT signaling resulted in a synergistic increase in CA-4P-mediated CTGF induction. CA-4P-mediated expression of CTGF was thus potentiated by the inhibition of kinase pathways, which are targets of novel antineoplastic drugs. Up-regulation of CTGF by low concentrations of CA-4P may thus occur in newly formed tumor vessels and contribute to the microvessel destabilization and antiangiogenic effects of CA-4P observed in vivo."}],"intvolume":" 7"}